Neuropsychobiology
October 20, 2010
Andrew Scholey, Lauren Owen, J. R. Gates et al.
46 citations
<i>Aims:</i> Our group has conducted several Internet investigations into the biobehavioural effects of self-reported recreational use of MDMA (3,4-methylenedioxymethamphetamine or Ecstasy) and other psychosocial drugs. Here we report a new study examining the relationship between self-reported Ecstasy use and traces of MDMA found in hair samples. <i>Methods:</i> In a laboratory setting, 49...
Addictive behaviors
June 2004
Andrew B Scholey, Andrew C Parrott, Tom Buchanan et al.
Recreational Ecstasy/MDMA (3,4-methylenedioxymethamphetamine) users often take a variety of psychoactive drugs, but there is little empirical data on how these drug consumption patterns change with greater experience of Ecstasy. The aim of this study was to compare the polydrug usage patterns reported by non-Ecstasy users, novice Ecstasy users, moderate Ecstasy users, and heavy Ecstasy users....
Human Psychopharmacology Clinical and Experimental
July 12, 2002
A. C. Parrott, Tom Buchanan, Andrew Scholey et al.
163 citations
Abstract Rationale The recreational use of MDMA/Ecstasy (3,4‐methylenedioxymethamphetamine) is associated with many psychobiological problems, but there is a paucity of data on how these relate to the level of past use. Objectives: to assess the incidence of Ecstasy‐attributed problems as reported by novice, moderate and heavy users. Methods: 763 unpaid volunteers took part in a WWW study of...
Human Psychopharmacology Clinical and Experimental
May 9, 2001
Thomas Heffernan, Jonathan Ling, Andrew Scholey
57 citations
Abstract Chronic use of MDMA (3,4‐methylenedioxymethamphetamine), or ‘ecstasy’, is associated with significant cognitive impairments, particularly in laboratory and field tests of memory for previously encoded material. Less is known about the effects of a history of MDMA use on aspects of everyday cognitive functioning–of which prospective memory (typically characterised as ‘remembering to do...